• Product NameNaringin
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityNaringin is a flavanone glycoside, which exerts a variety of pharmacological effects such as antioxidant activity, blood lipid lowering, antiY activity, and inhibition of cytochrome P450 enzymes.
• Target NameP450 antagonist
• CAS No. 10236-47-2
• Calculated MW 580.53
• Formulation C27H32O14
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C4C(=O)C[C@H](OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O
  Pathways:Metabolism
  Receptor:CYP450
  Boling pt:
  Melting pt:166C
  Solubility:Ethanol: 2 mg/mL (3.44 mM); DMSO: 116 mg/mL (199.81 mM)
  Appearance:Faint Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Ueng YF, et al. Life Sci, 1999, 65(24), 2591-2602.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting